Ukuze ukhuthaze kangcono ukusatshalaliswa kwesiko le-Limin Ngokuvunywa kwabaholi beqembu, hlela futhi wenze imisebenzi yokufunda ne-inthanethi yesiko lebhizinisi ngaphakathi kwezinkampani zeqembu.
Ntambama kaJulayi 6th, uVeyong Pharma wabamba umncintiswano wolwazi lwamasiko weCorporate ngesihloko se- "Isiko kuholela isifiso sokuqala, futhi ugxile ekwakheni umbono". Bangu-21 abagqugquzeli abangama-21 abavela kumaqembu ayi-7 avela kuma-workshop ahlukene kanye neminyango ebambe iqhaza emcimbini. Umncintiswano wolwazi ubuqine futhi uyaphila futhi uyathakazelisa, ohlanganisa intshiseko yawo wonke umuntu kanye nokuqala kokufunda. Esinyathelweni esilandelayo, inkampani izothuthukisa kakhulu umqondo wesiko elihlanganayo, yahlakulela abantu, abantu abafudumele ngamasiko, baqoqe abantu ngesiko; Vumela isiko elihlanganayo linikeze amandla aqinile ngokomoya kanye nokusekelwa kwamasiko okuthuthuka okuphezulu kwenkampani.
UVeyong unamathela endleleni yokuthuthuka "ehlanganisa ukuthuthukiswa kwe-R & D, ukwethula ubuchwepheshe", ukuthuthukisa ngokuqhubekayo imikhiqizo emisha futhi uthuthukise imikhiqizo emisha ukuthuthukisa amakhasimende afanelekile wemithi.
UVeyong uthatha "ukuba nekhono nge-biotechnology, ekwakheni impilo esezingeni eliphakeme" njenge-mission, ilwela ukuba ngumkhiqizo wezidakamizwa wezilwane obaluleke kakhulu, futhi ubheke phambili ukubambisana okusebenzayo namakhasimende omhlaba wonkeIvermectin, tiamulin hydrogen fumarate, I-Oxytetracycline Hydroclorloridekanye namalungiselelo.
Isikhathi Sokuposa: Jul-18-2022
.png)
.png)
.png)
.png)